The U.S. Food and Drug Administration is reportedly mulling whether more prescription drugs should be sold over the counter (OTC) at pharmacies. In an interview on Wednesday, FDA commissioner Martin ...

Food and Drug Administration Commissioner Marty Makary told CNBC that his view is that "everything should be over the counter" unless a drug is unsafe, addictive or requires monitoring. He said the ...

At last week's launch of TrumpRx, President Trump described the discounted drug platform as "one of the most transformative health care initiatives of all time." But experts and health care advocates ...

President Trump's new TrumpRx online platform is a key part of his plan to help lower drug costs for consumers, with some polls showing two-thirds of Americans report high health care costs as their ...

Add Yahoo as a preferred source to see more of our stories on Google. U.S. President Donald Trump introduces the new TrumpRx website in the South Court Auditorium of the White House in Washington, D.C ...

President Donald Trump unveiled TrumpRx.gov, a new government-backed website aimed at giving Americans access to discounted prescription drugs. Speaking at the website launch Thursday evening at the ...

John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. Emory is the data editor at ...

The Trump administration’s promised direct-to-consumer drug platform TrumpRx has officially gone live, with President Trump on Thursday calling it “one of the most transformative health care ...

President Donald Trump put his personal stamp Thursday night on a new government website, TrumpRx, aimed at helping Americans buy medicines at lower prices. "This is a very big deal," Trump said Feb.

This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund and the Robert Wood Johnson Foundation.

WASHINGTON (AP) — The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the ...